Cinchocaine - USP
CAS: 85-79-0
Ref. 3D-FC33247
10g | 136,00 € | ||
25g | 184,00 € | ||
50g | 303,00 € | ||
100g | 406,00 € | ||
250g | 542,00 € |
Produktinformation
- Dibucaine
- 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
- 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide
- 2-Butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
- 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide
- 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- Cinchocain
- Cinchocaine
- Cinchocaine Base
- Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- Mehr Synonyme anzeigen
- Cincocainio
- Dermacaine
- Dibucaine (base and/or unspecified salts)
- Dibucaine Free Base Crystalline
- Dibucaine Solution
- Dibucaine Usp
- Dibucaine base
- N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide
- Nsc 159055
- Nupercainal
- Nupercaine
- Percamine
Cinchocaine is a local anesthetic, which is used to relieve pain. Cinchocaine is a member of the amide class of local anesthetics. It has been shown to have neuronal death and mitochondrial membrane potential-inhibiting properties. Cinchocaine also binds to the hydrophobic region of voltage-sensitive potassium channels (Kv1.2), resulting in their closure and preventing action potentials from propagating through the neuron. The optimum concentration for cinchocaine is 0.1% (w/v). The optimal pH range for cinchocaine is 7.0 - 8.0, with a phase transition temperature of 78°C and a melting point of 117°C. Cinchocaine has been shown to be effective in animal models at concentrations as low as 10 µg/mL, with significant therapeutic effects observed at concentrations greater than 50 µg/mL
Chemische Eigenschaften
Technische Anfrage zu: 3D-FC33247 Cinchocaine - USP
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.